Marco Costantini

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Venues

Human vaccines & immunotherapeutics

Drug safety

Clinical and experimental vaccine research

GlaxoSmithKline

Libera Università Internazionale degli Studi Sociali Guido Carli (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Mar 01 2015

Italy

Lead Statistician :: Clinical Development

Novartis Sep 01 2010 - Feb 28 2015

Italy

Senior Statistician :: Clinical Deelopment

Chiesi Farmaceutici Spa Nov 02 2006 - Aug 31 2010

Italy

Senior Statistician :: R&D

Education History

Libera Università Internazionale degli Studi Sociali Guido Carli Nov 11 2014 - Dec 15 2015

Italy

MSC

London School of Hygiene and Tropical Medicine Department of Medical Statistics Sep 01 2004 - Sep 01 2005

United Kingdom

MSC

Publications

Puneet Vir Singh, Paola Tiberi, Gabriele Filippo Di Domenico, Valerio Romolini, Thembile Mzolo, Marco Costantini, Tauseefullah Akhund, Venere Basile, Maria Lattanzi, Michele Pellegrini
Fully Liquid MenACWY-CRM Vaccine: Results from an Integrated Safety Analysis. Drug safety (2022)
Javier Diez-Domingo, Juan Carlos Tinoco, Airi Poder, Ener Cagri Dinleyici, Haylene Nell, Ignacio Salamanca de la Cueva, Tolga Ince, Edson Duarte Moreira Júnior, Khatija Ahmed, Kleber Luz, Yulia Kovshirina, Carlos Eduardo Medina Pech, Tauseefullah Akhund, Valerio Romolini, Marco Costantini, Thembile Mzolo, Barry Kunnel, Isabelle Lechevin, Marianna Aggravi, Paola Tiberi, K Narendran, Juan-Antonio Garcia-Martinez, Venere Basile, Elena Fragapane, Maria Lattanzi, Michele Pellegrini
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults. Human vaccines & immunotherapeutics (2021)
Marzia Monica Giuliani, Alessia Biolchi, Pavitra Keshavan, Maria Moriondo, Sara Tomei, Laura Santini, Elena Mori, Alessandro Brozzi, Margherita Bodini, Francesco Nieddu, Silvia Ricci, Thembile Mzolo, Marco Costantini, Chiara Azzari, Michele Pellegrini
Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children. Human vaccines & immunotherapeutics 17 (5) (2020)
Hoan-Jong Lee, Dae Sun Jo, Yun Kyung Kim, Hyunju Lee, Kyung Hyo Kim, Dokyung Lee, Carlo Curina, Marco Costantini, Silvia Barbi, Yan Miao, Michele Pellegrini
One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea. Clinical and experimental vaccine research 8 (2) (2019)

Marco Costantini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Costantini